Search

Displaying results 9671 - 9680 of 10000 in total
  1. Drug

    Xininurad

    go.drugbank.com/drugs/DB21564
    Experimental

    Xininurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Xininurad is a urate transporter inhibitor.

  2. Drug

    Ansornitinib

    go.drugbank.com/drugs/DB21577
    Experimental

    Ansornitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor.

  3. Drug

    Garsorasib

    go.drugbank.com/drugs/DB21581
    Investigational

    Garsorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight of 598.26 Da.

  4. Drug

    Gumelutamide

    go.drugbank.com/drugs/DB21615
    Experimental

    Gumelutamide is a small molecule drug. The usage of the INN stem '-lutamide' in the name indicates that Gumelutamide is a non-steroid antiandrogen.

  5. Drug

    Frevecitinib

    go.drugbank.com/drugs/DB21681
    Investigational

    Frevecitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Frevecitinib is a Janus kinase inhibitor.

  6. Drug

    Odentegravir

    go.drugbank.com/drugs/DB21708
    Experimental

    Odentegravir is a small molecule drug. The usage of the INN stem '-tegravir' in the name indicates that Odentegravir is a HIV integrase inhibitor.

  7. Drug

    PF-06305591

    go.drugbank.com/drugs/DB12106
    Investigational

    Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).

  8. Drug

    MGB-BP-3

    go.drugbank.com/drugs/DB12892
    Investigational

    Mgb Bp 3 is under investigation in clinical trial NCT02518607 (Safety, Blood Levels and Effects of MGB-BP-3).

  9. Drug

    PX-102

    go.drugbank.com/drugs/DB15416
    Investigational

    PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study With Px-102).

  10. Drug

    PF-05105679

    go.drugbank.com/drugs/DB15450
    Investigational

    PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).